Biopharmas raising money in public or private financings, including: Ionctura, Lipella.

Biopharmas raising money in public or private financings, including: Alvotech, Aptorum, Evelo, Harrow, Jalon, Ose, Soleno.

Biopharmas raising money in public or private financings, including: Avidity, Biondvax, IMV, Novavax.

Minervax Aps has closed a €72 million (US$76.6 million) financing round, enabling it to accelerate phase II development of its group B streptococcus (GBS) vaccine for the prevention of stillbirth and serious infections in newborns and complete the program next year.

Biopharmas raising money in public or private financings, including: Alternative, Astria, Avidity, Biocardia, Checkpoint, Enlaza, Gilgamesh, Novavax, Prothena, Syndax.

Biopharmas raising money in public or private financings, including: Alpha-9, Carocell, Etcembly, Montai, NLS, Prothena, Psyence.

Biopharmas raising money in public or private financings, including: Amphista, Contrafect, Peroxitech, Tellus.

Biopharmas raising money in public or private financings, including: Adma, Aptose, Black Diamond, Celcuity, Clene, Immunitybio, Inventiva.